secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001477932-22-008884
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx Chief Medical Officer Dr. Jason Terrell resigns effective Nov 18, 2022
--------------------------------------------------------------------------------

- Dr. Jason Terrell resigned as Chief Medical Officer on November 22, 2022, effective retroactively to November 18, 2022.
- Company thanked Dr. Terrell for his contributions and wished him success.
- No replacement for the CMO position was announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793222008884/0001477932-22-008884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793222008884/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-008884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer